<DOC>
	<DOCNO>NCT00865826</DOCNO>
	<brief_summary>An estimate 3 million HIV-infected individual enter program antiretroviral ( ARV ) treatment come year , project rate requirement ARV therapy extend 10 million sub-Saharan Africa , southeastern Asia , Latin America come decade . In setting , Tuberculosis ( TB ) endemic infection population , estimate 30-60 % adult infected TB , lead opportunistic infection associate HIV infection . The purpose study construct standardize diagnostic evaluation ( SDE ) TB provide increase identification participant active pulmonary TB , without sacrifice specificity .</brief_summary>
	<brief_title>Observational Study Specificity Mycobacterium Tuberculosis Screening Diagnostics HIV-Infected Individuals</brief_title>
	<detailed_description>Well develop TB diagnostic testing , contact tracing , treatment program key part public health health care infrastructure many country HIV infection result 3- 10-fold increase clinical TB , accompany increase HIV prevalence . The primary purpose study construct standardize diagnostic evaluation ( SDE ) TB provide increase identification participant active pulmonary TB , without sacrifice specificity . This observational study include participant HIV-infected TB-uninfected receiving ARV therapy . The duration trial last 1 14 day . Screening study entry may occur visit . All evaluation must perform within 14 day participant register . Medical medication history , physical exam , oral examination swab , chest x-ray , sputum blood collection , documentation PPD/TST ( available ) occur within 14-day period .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Tuberculosis</mesh_term>
	<mesh_term>Mycobacterium Infections</mesh_term>
	<criteria>HIVinfected Receipt ART within 90 day prior study entry Diagnosis active TB ( pulmonary extrapulmonary ) within 90 day prior study entry Receipt 7 cumulative day certain medication within 90 day prior study entry . More information criterion find protocol .</criteria>
	<gender>All</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Pulmonary Tuberculosis</keyword>
	<keyword>Myobacterium Infections</keyword>
</DOC>